StockData
GERNNasdaqPharmaceutical PreparationsFiscal year ends December 31

GERON CORP

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$1.20+0.03 (+2.56%)

Close on Oct 19, 2026

Market cap
$804.84K
P/E (TTM)
–
Dividend yield
–

GERON CORP revenue by segment

By business segment

By product or service

RevenueQ2 26Q1 26Q4 25Q3 25Q2 25Q1 25Q4 24Q3 24Q2 24Q1 24Q4 23Q3 23% of revenueYoY
Gross product revenue$72.44M$65.35M$59.74M$60.19M$57.87M$45.31M$55.87M$32.66M$890.00K$0––126.0%+25.2%
Product revenue, net$57.47M$51.77M$48.01M$47.17M$49.01M$39.44M$47.51M$28.21M$780.00K$0––100.0%+17.3%
Royalties$7.00K$66.00K$2.00K$60.00K$29.00K$167.00K$31.00K$62.00K$102.00K$304.00K$23.00K$164.00K0.0%-75.9%
Sales returns and allowances-$1.43M-$1.59M–-$1.80M-$518.00K-$113.00K–-$82.00K-$2.00K$0––-2.5%+176.6%
Government rebates-$1.97M-$1.66M$65.00K-$2.14M-$459.00K-$66.00K–-$364.00K-$11.00K$0––-3.4%+329.0%
Distributor service fees-$2.37M-$2.17M––-$1.95M-$1.53M––––––-4.1%+21.6%
Chargebacks-$9.19M-$8.16M––-$5.94M-$4.17M––––––-16.0%+54.7%
Total gross-to-net adjustments-$14.96M-$13.58M–-$13.02M-$8.87M-$5.88M–-$4.45M-$110.00K$0––-26.0%+68.7%
Chargebacks and customer credits–––-$9.08M-$7.89M-$5.70M–-$4.00M-$97.00K$0––––
Chargebacks and distributor service fees–––––––-$4.00M-$97.00K–––––

By region

From the segment and revenue-disaggregation notes of Geron's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.